Bitterman Robert J bought 25,000 shares of Phio Pharmaceuticals Corp. at $0.82 for $20.5k on Nov 9, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chairman, Pres. & CEO
Chairman, Pres. & CEO
Filed Nov 10, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$20,500Shares × reported price
Shares traded
25,000Common Stock, $.0001 par value
Price per share
$0.82Reported price. Read footnotes for ranges.
% of reported position traded
3.27%This security and ownership context
Holdings after
789,871Direct
Trade date
Nov 9, 2026Buy
Filed
Nov 10, 2026, 11:17 AM ET1-day reporting delay
Accession
0001683168-26-008469Code P · Transaction 396732
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 764,871 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PHIO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PHIO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +13%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Includes shares of common stock underlying unvested restricted stock units.